Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist manufactured by Novo Nordisk that is approved by the U.S. Food ...

The Food and Drug Administration approved a first-of-its-kind pill that can reduce cholesterol in a way that’s previously ...

The Trump administration will launch its pilot program on Wednesday. It lasts 18 months, and estimated costs to taxpayers have not been disclosed.

The FDA just approved a new drug for use in ER+/HER2- metastatic breast cancer, based on a large study led by Fred Hutch's Dr ...

Popular weight loss drugs like Ozempic and Wegovy are now widely used in India for obesity treatment These drugs mimic GLP-1 hormone to suppress appetite and support diabetes and obesity management ...

Approval of iohexol injection 350 mg iodine/mL in 50 mL, 75 mL and 100 mL vials, and 300 mg iodine/mL in 50 mL vial, significantly expands ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Chemotherapy drugs ...

Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program that launches July 1.

Background Fibrosis and tumour innervation are two features of the tumour microenvironment (TME) that contribute directly to the lethality of pancreatic ductal adenocarcinoma (PDAC), but their ...

The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans.

CHARLOTTE, N.C. (QUEEN CITY NEWS) — As the popularity of GLP-1 medications for weight loss continues to soar, experts in Charlotte are raising concerns about what happens after millions of Americans ...

A generic semaglutide injection to promote weight loss is now approved in Canada, Health Canada says. The regulator said the product submission, called Svemia, was filed by Canadian-based Apotex and ...